Selected research
Industry Research
Cell Biology Services Industry Research Report 2026
Market perspective
The global Cell Biology Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Biology Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Biology Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Biology Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Biology Services include Eurofins Scientific, WuXi AppTec, Labcorp Drug Development, IQVIA Laboratories, Crown Bioscience, BioIVT, GenScript, Creative Bioarray and Creative Biogene, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Biology Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Biology Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Biology Services Market by Company
Eurofins Scientific
WuXi AppTec
Labcorp Drug Development
IQVIA Laboratories
Crown Bioscience
BioIVT
GenScript
Creative Bioarray
Creative Biogene
Abzena
Syngene International
Evotec
FUJIFILM Cellular Dynamics
ReproCELL
Takara Bio
Thermo Fisher Scientific
Charles River Laboratories
Lonza
Cell Biology Services Segment by Type
Manufacturing
Testing
Cell Biology Services Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic & Research Institutes
Hospitals & Clinical Research Centers
Others
Cell Biology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Biology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Biology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Biology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Biology Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Manufacturing
- Testing
Applications
- Pharmaceutical Companies
- Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Clinical Research Centers
- Others
Companies covered
- Eurofins Scientific
- WuXi AppTec
- Labcorp Drug Development
- IQVIA Laboratories
- Crown Bioscience
- BioIVT
- GenScript
- Creative Bioarray
- Creative Biogene
- Abzena
- Syngene International
- Evotec
- FUJIFILM Cellular Dynamics
- ReproCELL
- Takara Bio
- Thermo Fisher Scientific
- Charles River Laboratories
- Lonza
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Biology Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Manufacturing
- 2.2.3 Testing
- 2.3 Cell Biology Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Biotechnology Companies
- 2.3.4 Academic & Research Institutes
- 2.3.5 Hospitals & Clinical Research Centers
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Cell Biology Services Breakdown Data by Type
- 3.1 Global Cell Biology Services Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Biology Services Forecasted Market Size by Type (2027-2032)
4 Cell Biology Services Breakdown Data by Application
- 4.1 Global Cell Biology Services Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Biology Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Biology Services Market Perspective (2021-2032)
- 5.2 Global Cell Biology Services Growth Trends by Region
- 5.2.1 Global Cell Biology Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Biology Services Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Biology Services Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Biology Services Market Dynamics
- 5.3.1 Cell Biology Services Industry Trends
- 5.3.2 Cell Biology Services Market Drivers
- 5.3.3 Cell Biology Services Market Challenges
- 5.3.4 Cell Biology Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Biology Services Players by Revenue
- 6.1.1 Global Top Cell Biology Services Players by Revenue (2021-2026)
- 6.1.2 Global Cell Biology Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Biology Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Biology Services Head Office and Area Served
- 6.4 Global Cell Biology Services Players, Product Type & Application
- 6.5 Global Cell Biology Services Manufacturers Established Date
- 6.6 Global Cell Biology Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Biology Services Market Size (2021-2032)
- 7.2 North America Cell Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Biology Services Market Size by Country (2021-2026)
- 7.4 North America Cell Biology Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Biology Services Market Size (2021-2032)
- 8.2 Europe Cell Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Biology Services Market Size by Country (2021-2026)
- 8.4 Europe Cell Biology Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Biology Services Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Biology Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Biology Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Biology Services Market Size (2021-2032)
- 10.2 South America Cell Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Biology Services Market Size by Country (2021-2026)
- 10.4 South America Cell Biology Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Biology Services Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Biology Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Biology Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Cell Biology Services Business (2021-2026)
- 12.1.4 Eurofins Scientific Cell Biology Services Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 WuXi AppTec
- 12.2.1 WuXi AppTec Company Information
- 12.2.2 WuXi AppTec Business Overview
- 12.2.3 WuXi AppTec Revenue in Cell Biology Services Business (2021-2026)
- 12.2.4 WuXi AppTec Cell Biology Services Product Portfolio
- 12.2.5 WuXi AppTec Recent Developments
- 12.3 Labcorp Drug Development
- 12.3.1 Labcorp Drug Development Company Information
- 12.3.2 Labcorp Drug Development Business Overview
- 12.3.3 Labcorp Drug Development Revenue in Cell Biology Services Business (2021-2026)
- 12.3.4 Labcorp Drug Development Cell Biology Services Product Portfolio
- 12.3.5 Labcorp Drug Development Recent Developments
- 12.4 IQVIA Laboratories
- 12.4.1 IQVIA Laboratories Company Information
- 12.4.2 IQVIA Laboratories Business Overview
- 12.4.3 IQVIA Laboratories Revenue in Cell Biology Services Business (2021-2026)
- 12.4.4 IQVIA Laboratories Cell Biology Services Product Portfolio
- 12.4.5 IQVIA Laboratories Recent Developments
- 12.5 Crown Bioscience
- 12.5.1 Crown Bioscience Company Information
- 12.5.2 Crown Bioscience Business Overview
- 12.5.3 Crown Bioscience Revenue in Cell Biology Services Business (2021-2026)
- 12.5.4 Crown Bioscience Cell Biology Services Product Portfolio
- 12.5.5 Crown Bioscience Recent Developments
- 12.6 BioIVT
- 12.6.1 BioIVT Company Information
- 12.6.2 BioIVT Business Overview
- 12.6.3 BioIVT Revenue in Cell Biology Services Business (2021-2026)
- 12.6.4 BioIVT Cell Biology Services Product Portfolio
- 12.6.5 BioIVT Recent Developments
- 12.7 GenScript
- 12.7.1 GenScript Company Information
- 12.7.2 GenScript Business Overview
- 12.7.3 GenScript Revenue in Cell Biology Services Business (2021-2026)
- 12.7.4 GenScript Cell Biology Services Product Portfolio
- 12.7.5 GenScript Recent Developments
- 12.8 Creative Bioarray
- 12.8.1 Creative Bioarray Company Information
- 12.8.2 Creative Bioarray Business Overview
- 12.8.3 Creative Bioarray Revenue in Cell Biology Services Business (2021-2026)
- 12.8.4 Creative Bioarray Cell Biology Services Product Portfolio
- 12.8.5 Creative Bioarray Recent Developments
- 12.9 Creative Biogene
- 12.9.1 Creative Biogene Company Information
- 12.9.2 Creative Biogene Business Overview
- 12.9.3 Creative Biogene Revenue in Cell Biology Services Business (2021-2026)
- 12.9.4 Creative Biogene Cell Biology Services Product Portfolio
- 12.9.5 Creative Biogene Recent Developments
- 12.10 Abzena
- 12.10.1 Abzena Company Information
- 12.10.2 Abzena Business Overview
- 12.10.3 Abzena Revenue in Cell Biology Services Business (2021-2026)
- 12.10.4 Abzena Cell Biology Services Product Portfolio
- 12.10.5 Abzena Recent Developments
- 12.11 Syngene International
- 12.11.1 Syngene International Company Information
- 12.11.2 Syngene International Business Overview
- 12.11.3 Syngene International Revenue in Cell Biology Services Business (2021-2026)
- 12.11.4 Syngene International Cell Biology Services Product Portfolio
- 12.11.5 Syngene International Recent Developments
- 12.12 Evotec
- 12.12.1 Evotec Company Information
- 12.12.2 Evotec Business Overview
- 12.12.3 Evotec Revenue in Cell Biology Services Business (2021-2026)
- 12.12.4 Evotec Cell Biology Services Product Portfolio
- 12.12.5 Evotec Recent Developments
- 12.13 FUJIFILM Cellular Dynamics
- 12.13.1 FUJIFILM Cellular Dynamics Company Information
- 12.13.2 FUJIFILM Cellular Dynamics Business Overview
- 12.13.3 FUJIFILM Cellular Dynamics Revenue in Cell Biology Services Business (2021-2026)
- 12.13.4 FUJIFILM Cellular Dynamics Cell Biology Services Product Portfolio
- 12.13.5 FUJIFILM Cellular Dynamics Recent Developments
- 12.14 ReproCELL
- 12.14.1 ReproCELL Company Information
- 12.14.2 ReproCELL Business Overview
- 12.14.3 ReproCELL Revenue in Cell Biology Services Business (2021-2026)
- 12.14.4 ReproCELL Cell Biology Services Product Portfolio
- 12.14.5 ReproCELL Recent Developments
- 12.15 Takara Bio
- 12.15.1 Takara Bio Company Information
- 12.15.2 Takara Bio Business Overview
- 12.15.3 Takara Bio Revenue in Cell Biology Services Business (2021-2026)
- 12.15.4 Takara Bio Cell Biology Services Product Portfolio
- 12.15.5 Takara Bio Recent Developments
- 12.16 Thermo Fisher Scientific
- 12.16.1 Thermo Fisher Scientific Company Information
- 12.16.2 Thermo Fisher Scientific Business Overview
- 12.16.3 Thermo Fisher Scientific Revenue in Cell Biology Services Business (2021-2026)
- 12.16.4 Thermo Fisher Scientific Cell Biology Services Product Portfolio
- 12.16.5 Thermo Fisher Scientific Recent Developments
- 12.17 Charles River Laboratories
- 12.17.1 Charles River Laboratories Company Information
- 12.17.2 Charles River Laboratories Business Overview
- 12.17.3 Charles River Laboratories Revenue in Cell Biology Services Business (2021-2026)
- 12.17.4 Charles River Laboratories Cell Biology Services Product Portfolio
- 12.17.5 Charles River Laboratories Recent Developments
- 12.18 Lonza
- 12.18.1 Lonza Company Information
- 12.18.2 Lonza Business Overview
- 12.18.3 Lonza Revenue in Cell Biology Services Business (2021-2026)
- 12.18.4 Lonza Cell Biology Services Product Portfolio
- 12.18.5 Lonza Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst